Michael J. Lim, MD

Clinical Editor's Corner

Turnover of Cath Lab Staff: Is Complexity to Blame?

04/03/2022

Lloyd W. Klein , MD;

Morton J. Kern , MD, MSCAI, FACC, FAHA;

Andrew Youmans , RN;

Michael J. Lim , MD;

Stephen R. Ramee , MD;

Dr. Kern and other expert contributors recently discussed TAVR: Who Should Prep the Device?1 (January 2022), outlining the role of industry representatives compared to cath lab staff. In this article, several contributors cited the staffing...

Dr. Kern and other expert...

04/03/2022

Cath Lab Digest

Commentary

The Angiojet Rheolytic Thrombectomy System: Does the End Justify the Means?

08/01/2008

Michael J. Lim , MD;

Percutaneous treatment of patients with a visible intracoronary thrombus has been recognized as a procedure associated with higher risk for complications. For patients with intracoronary thrombus in the stent era, the potentially worse...

Percutaneous treatment of...

08/01/2008

Journal of Invasive Cardiology

Feature

Advanced Imaging Technology in the Detection of Coronary Artery Disease: One Step at a Time

06/19/2008

Michael J. Lim , MD;

In 1958, while performing an ascending aortogram, the tip of Mason Sones’ catheter inadvertently cannulated the right coronary artery and injected contrast material. The patient survived and thus began a new paradigm of investigation for the...

In 1958, while performing an...

06/19/2008

Cath Lab Digest

Feature

The 2005 ACC/AHA/SCAI Percutaneous CoronaryIntervention Guidelines:Summarizing changes and some of the major recommendations

06/19/2008

Morton J. Kern , MD, MSCAI, FACC, FAHA;

Michael J. Lim , MD;

It is important to keep in mind that these guideline documents are created in an attempt to define practices to meet the needs of most patients encountered in clinical practice. In creating these recommendations, a writing group reviews the...

It is important to keep in mind...

06/19/2008

Cath Lab Digest

Feature

Advancing the Field of Coronary Intervention: Magnetic Guidewire Navigation

06/19/2008

Michael J. Lim , MD;

Why Do We Need Such Technology? While the currently available guide catheters, highly specialized guidewires, and transit catheters have allowed operators to gain access to distal vasculature not reachable five years ago, we still run into...

Why Do We Need Such...

06/19/2008

Cath Lab Digest

Clinical Editor's Corner

What Should We Do With an Anomalous Coronary Artery (ALCA) With a Malignant Left Main Course in an Asymptomatic Patient?

05/07/2018

Morton J. Kern , MD, MSCAI, FACC, FAHA;

Michael J. Lim , MD;

John W. Hirshfeld Jr.;

Kirk N. Garratt , MD, MSc;

Christopher J. White , DO, MD;

George W. Vetrovec , MD;

Jeannie Yu , MD;

Andrew Doorey ;

Pinak Bipin Shah ;

Jeffrey W. Moses , MD;

Paul S. Teirstein , MD, FACC;

William M. Suh , MD;

David E. Kandzari , MD;

Dr. Paul Teirstein, Chief of Cardiology, at Scripps Clinic, La Jolla, California, asked our cath lab experts for their opinions on what to do with an asymptomatic executive who had a screening CTA (Figure 1).

Dr. Paul Teirstein, Chief of...

05/07/2018

Cath Lab Digest